ISK Biosciences Europe SA
ISK Biosciences Europe reported revenue of €199.3m for the 2025 financial year (non-consolidated annual accounts filed with the NBB on 13 May 2026).
By total assets for 2025, ISK Biosciences Europe ranks among the 3 largest of the 21 companies in its sector (NACE 2020) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of ISK Biosciences Europe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +47 % Equity -9 % Total assets 0 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ISK Biosciences Europe's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 May 2026
- Year ended 31 Dec 2024filed on 15 May 2025
- Year ended 31 Dec 2023filed on 15 May 2024
- Year ended 31 Dec 2022filed on 16 May 2023
- Year ended 31 Dec 2021filed on 13 May 2022
ISK Biosciences Europe's financial analysis
- Solvency47.5%sector median: 49.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ISK Biosciences Europe
8 active director(s) in the register.
and 2 more
ISK Biosciences Europe's shareholders and holdings →ISK Biosciences Europe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0457.517.425
- VAT number
- BE0457517425
- Peppol
- Registered · 0208:0457517425 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 14 Mar 1996
- Registered office
- 1831 Machelen (Brab.)
- Latest accounts
- 2025 · filed on 13 May 2026
- Activity
- Manufacture of pesticides, disinfectants and other agrochemical products (NACE 20200)
ISK Biosciences Europe (SA) has been based in Machelen (Brab.) since 1996, active in: manufacture of pesticides, disinfectants and other agrochemical products. For 2025, it reports revenue of €199.3m, a net profit of — and equity of €79.9m. Its solvency stands at 47.5%, below the median of its sector (49.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to ISK Biosciences Europe
Companies in the same business, of comparable size and area, outside its group.
- Arysta Lifescience Benelux Manufacture of pesticides, disinfectants and other agrochemical products Seraing · balance sheet €195.8m
- Bayer Agriculture Manufacture of pesticides, disinfectants and other agrochemical products Antwerp · balance sheet €209.5m
- Evonik Antwerpen Manufacture of other inorganic basic chemicals Antwerp · balance sheet €331.9m
- Globachem Wholesale of chemical products Sint-Truiden · balance sheet €235.8m
- Novus Europe Wholesale of grain, unmanufactured tobacco, seeds and animal feeds Zaventem · balance sheet €75.6m
- Rousselot Manufacture of other chemical products n.e.c. Ghent · balance sheet €96.3m
- DMT Service Support activities for crop production Oudenaarde · balance sheet €25.4m
- Intergrow Wholesale of chemical products Aalter · balance sheet €60.2m
Frequently asked questions about ISK Biosciences Europe
What is the revenue of ISK Biosciences Europe?
According to the 2025 annual accounts filed with the NBB, the revenue of ISK Biosciences Europe amounts to 199,315,966 €.
What is the VAT number of ISK Biosciences Europe?
In Belgium, the VAT number is the company number prefixed with BE: BE0457517425 for ISK Biosciences Europe, if the company is VAT-registered. Its company number (CBE) is 0457.517.425.
Where is the registered office of ISK Biosciences Europe?
According to the CBE register, the registered office of ISK Biosciences Europe is in 1831 Machelen (Brab.).
What is the equity of ISK Biosciences Europe?
At the close of the 2025 financial year, the equity of ISK Biosciences Europe amounts to 79,895,808 €, a solvency of 47.5% of total assets.
Who manages ISK Biosciences Europe?
The register lists 8 active mandates at ISK Biosciences Europe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is ISK Biosciences Europe within its sector?
By total assets for 2025, ISK Biosciences Europe ranks among the 3 largest of the 21 companies in its sector (NACE 2020) in Belgium that filed accounts for that financial year.
The full file of ISK Biosciences Europe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →